White House advisers propose fast-tracking reviews of brand-name drugs to lower costs: 6 things to know

(By Alia Paavola for Becker’s Hospital Review)

White House advisers proposed the idea to expedite the review process for certain brand-name medications submitted to the FDA for approval as a way to lower drug prices, reports STAT. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.